Ige-mediated allergen presentation via fc epsilon rl on antigen-presenting cells

International Archives of Allergy and Immunology

Volumn 113, Issue 1-3, 1997, Pages 24-29

  Stingl, Georg ^a   Maurer, Dieter ^a  

^a Universitatsklinik fur Dermatologie   (Austria)

Author keywords

Antigen presenting cells; Atopic dermatitis; Dendritic cells; IgE receptors; IgE facilitated allergen presentation

Indexed keywords

ALLERGEN; FC RECEPTOR; IMMUNOGLOBULIN E RECEPTOR;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ATOPY; CONFERENCE PAPER; DENDRITIC CELL; LANGERHANS CELL; MONOCYTE; PRIORITY JOURNAL;

ALLERGENS; ANIMALS; ANTIGEN-PRESENTING CELLS; HUMANS; IMMUNOGLOBULIN E; RECEPTORS, IGE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0030965584     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000237499     Document Type: Article

References (46)

1. Coca RF, Cooke RA: On the classification of the phenomena of hypersensitivities. J Immunol 1923:8:163-182.
2. Bruynzeel-Koomen C, van Wichen DF, Toon-stra J, Berrens L, Bntynzcel PL: The presence of lgE molecules on epidermal Langcrhans cells in patients with atopic dermatitis. Arch Dermatol Res 1986;278:199-204.
3. Leung DYM, Schneeberger FE, Siraganian RP, Geha RS, Bhan AK: The presence of lgE on monocytes/macrophages infiltrating the skin lesions of atopic dermatits. Clin Immunol Im-munopathol 1987;42:328-337.
4. Bruynzeel-Koomen C, van der Donk EMM, Bruynzeel PLB, Capron M, de Gast GC, Mudde G: Associated expression of CD1 antigen and Fc receptor for lgE on epidermal Langerhans cells from patients with atopic dermatitis. Clin Exp Immunol 1988:74:137-142
5. Bieber T, Rieger A, Neuchrist C, Prinz JC, Rieber EP, Boltz-Nitulescu G, Schciner O, Kraft D, Ring J, Stingl D: Induction of Fct RII' CD23 on human epidermal Langerhans cells by human recombinant interleukin 4 and y interferon. J Exp Med 1989; 170:309-314.
6. Wang B, Rieger A, Kilgus O, Ochiai K, Maurer D, Födinger D, Kinet IP, Stingl G: Epidermal Langerhans cells from normal human skin bind monomeric IgE via FceRI. J Exp Med 1992: 175:1353-1365.
7. Bieber T, de la Salle H, Wollenberg A, Hakimi J, Chizzonite R, Ring J, Hanau D, de la Salle C: Human epidermal Langerhans cells express the high-affinity receptor for Immunoglobulin E (FceRI). J Exp Med 1992;175:1285-1290.
8. Haas N, Hamann K, Grabbe J, Cremer B. Czar-netzki BM: Expression of the high affinity IgE-rcceptor on human Langerhans cells. Acta Derm Venereol Suppl (Stockh) 1992:72:271-272.
9. Osterhoff B, Rappersberger C, Wang B, Koszik F, Ochiai K, Kinet J-P, Stingl G: Immuno-morphological characterization of FceRI-bcar-ing cells within the human dermis. J Invest Dermatol 1994:102:315-320
10. Klubal R, Osterhoff B, Wang B, Kinet J-P, Maurer D, Stingl G: The high-affinity receptor for IgE is the predominant IgE-binding structure in lesional skin of atopic dermatitis patients. J Invest Dermatol 1997. in press.
11. Maurer D, Fiebiger E, Ebner C, Reininger B, Fischer GF, Wichlas S, Jouvin M-H. Schmitt-Egenolf M, Kraft D, Kinet J-P, Stingl G: Peripheral blood dendritic cells express FceRI as a complex composed of FceRIα- and FceRIy-chains and can use this receptor for IgE-medi-ated allergen presentation. J Immunol 1996; 157:607-616.
12. Romani N, Grüner S, Brang D, Kumpgen E, Lenz A, Trockenbacher B, Konwalinka G, Fritsch PO, Steinman RM, Schuler G: Proliferating dendritic cell progenitors in peripheral blood. J Exp Med 1994; 180:83-93.
13. Dessaint JP, Capron A: Fee receptor Il-positive macrophages and platelets: Potent effector cells in allergy and defense against helminth parasites. Semin Immunopathol 1990:12:349-363.
14. Liu FT, Frigeri LT, Gritzmacher CA, Hsu DK, Robertson MW, Zuberi RI: Expression and function of an IgE-binding animal lectin (rBP) in mast cells, Immunopharmacology 1993:26: 187-195.
15. Maurer D, Fiebiger E, Reininger B, Wolff-Wi-niski B, Jouvin M-H, Kilgus O, Kinet J-P. Stingl G: Expression of functional high affinity IgE receptors (FceRI) on monocytes of atopic individuals. J Exp Med 1994:179:745-750.
16. Maurer D, Ebner C, Reininger B, Fiebiger E, Kraft D, Kinet J-P, Stingl G: The high affinity IgE receptor (FceRI) mediates IgE-depcndent allergen presentation. J Immunol 1995; 154: 6285-6290.
17. Ravetch J V, Kinet J-P: Fc receptors. Annu Rev Immunol 1991:9:547-592.
18. Alber G, Miller L, Jelsema C, Vatin-Blank N, Metzger II: Structure/function relationships of the mast cell high-affinity receptor for IgE (FceRI). J BiolChem 1991;266:22613-22620.
19. Mao SY, Alber G, Rivera J, Kochan J, Metzger II: Interaction of aggregated native and mutant IgE receptors with the cytoskeleton. Proc Natl Acad Sei USA 1992:89:222-226.
20. Reth M: Antigen receptor tail clue. Nature 1989:338:383-384.
21. Jouvin MHE, Adamczewski M, Numerof R, Letourneur O, Valle A, Kinet JP: Differential control of the tyrosine kinases lyn and syk by the two signaling chains of the high affinity Immunoglobulin E receptor. J Biol Chem 1994: 269:5918-5925.
22. Choi OH, Kim JH, Kinet J-P: Calcium mobilization via sphingosine kinase in signalling by the FceRI antigen receptor. Nature 1996:380: 634-636.
23. Lin S, Cicala C, Scharenberg AM, Kinet J-P: The Fee RIß subunit functions as an amplifier of FcrRI-mediated cell activation signals. Cell 1996;85:985-995.
24. Bieber T: FcrRI on human Langerhans cells: A receptor in search of new functions. Immunol Today 1994:15:52-53.
25. Ishizaka K: Basic mechanism of IgE-mediated hypersensitivity. Curr Opin Immunol 1989;4: 625-629.
26. Oming L, Hammarstrom S, Samuelsson B: Leukotriene D: A slow reacting substance from rat basophilic leukemia cells. Proc Natl Acad Sei USA 1980;77:2014-2017.
27. Ortega C, Hazan B, Zor U, Pceht I: Mast cell stimulation by monoclonal antibodies specific for the Fc, receptor yields distinct responses of arachidonic acid and leukotricnc C4 secretion. Eur J Immunol 1989:19:2251-2257.
28. Plaut M, Pierce JH, Watson CJ, Hanley-Hyde J, Nordan RP, Paul WE: Mast cell lines produce lymphokines in response to cross-linkage of FcrRI orto calcium ionophor. Nature 1989:339: 64-67.
29. Wodnar-Filipoviez A, Heusser CH, Moroni C: Production of the hemopoietic growth factors GM-CSF and interleukin-3 by mast cells in response to IgE receptor-mediated activation. Na-ture 1989:339:150-152.
30. Burd RP, Rogers IIW, Gordon JR, Martin CA, Jayaraman S, Wilson SD, Dvorak AM, Galli SJ, Dorf ME: lnterleukin-3 dependent and independent mast cells stimulated with IgE and antigen express multiple cytokines. J Exp Med 1989;170:245-257.
31. Ifeufler C, Topar G, Koch F, Trockenbacher B, Kätrpgen E, Romani N, Schuler G: Cytokine gene expression in murine epidermal cell suspensions: Interleukin 13 and macrophage inflammatory protein I« arc selectively expressed in Langerhans cells but are differently regulated in culture. J Exp Med 1992:176: 1221-1226.
32. Matsue H, Cruz PD Jr., Bergstresser PR: Langerhans cells are the major source of mRNA for IL-lβ and MIP-1α among unstimulated mouse epidermal cells. J Invest Dermatol 1992;99: 537-541.
33. Schreiber S, Kilgus O, Payer E, Kutil R, Elbe A, Müller C, Stingl G: Cytokine pattern of Langer-hans cells isolated from murine epidermal cell cultures. J Immunol 1992:149:3524-3534.
34. Nathan CF: Secretory products of macrophages. J Clin Invest 1987:79:319-326.
35. Borish E, Mascali JJ, Rosenwasser LI: IgE-de-pendent cytokine production by human peripheral blood mononuclear phagocytes. J Immunol 1991:146:63-67.
36. Ferreri NR, Howland WC, Spiegelberg HL: Release of leukotrienes C4 and B4 and prostaglandin E2 from human monocytes stimulated with aggregated IgG, IgA.and IgE. J Immunol 1986: 136:4188-4193.
37. Rankin JA, Hitehcock M, Marrill WW, Bach MK, Brashler JR, Askenase PW: IgE-dcpend-ent release of leukotricnc C4 from alveolar macrophages. Nature 1982:297:329-331.
38. Valenta R, Maurer D, Steiner R. Seiberler S, Sperr WR, Valent P, Spitzauer S, Kapiotis S, Smolen J, Stingl G: Immunoglobulin E response to human proteins in atopic patients. J Invest Dermatol 1996;107:203-208.
39. Leung DYM, Pober JS, Cotran RS: Expression of endothelial leukocyte adhesion molecule-1 (ELAM-I) in elicited late phase allergic reactions. J Clin Invest 1991;87:1805-1809.
40. Mullarkey MF, Leiferman KM, Peters MS, Caro I, Roux ER, Hanna RK, Rubin AS. Jacobs CA: Human cutaneous allergic late-phase response is inhibited by soluble IL-I receptor. J Immunol 1994;152:2033-2041.
41. Petzelbauer P, Bender J, Wilson J, Pober JS: Heterogeneity of dermal microvascular endothelial cell antigen expression and cytokine responsiveness in situ and in cell culture. J Immunol 1993:151:5062-5072.
42. Springer, TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 1994;76:301-314.
43. Van der Heijden FC, Wierenga EA, Bos JD, KapsenbergJL: High frequency of IL-4 producing CD4+ allergen-specific T lymphocytes in atopic dermatitis lesional skin. J Invest Dermatol 1991;97:389-394.
44. Kay AB, Ying S, Varney V, Gaga M, Durham SR, Moqbel R, Wardlaw AJ, Hamid Q: Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4. IL-5, and granulocyte/macrophage colony-stimulating factor. in allergen-induced latc-phasc cutaneous reactions in atopic subjects. J Exp Med 1991; 173:775-778.
45. Hamid Q, Boguniewiez M, Leung DYM: Differential in situ gene expression in acute versus chronic atopic dermatitis. J Clin Invest 1994; 94:870-876.
46. Müller KM, Jaunin F, Masouyé I, Saurat J-H, Hauser C: Th2 cells mediate IL-4-depcndcnt local tissue inflammation. J Immunol 1993; 150: 5576-5584